Literature DB >> 28178492

The ASGCT in 2012: Charting a Path to Bring Novel Biologic Therapies to the Clinic.

Xandra O Breakefield.   

Abstract

Year:  2016        PMID： 28178492      PMCID： PMC3392989          DOI： 10.1038/mt.2012.122

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  4 in total

1.  It's time for gene therapy to get disruptive!

Authors:  James M Wilson
Journal:  Hum Gene Ther       Date:  2012-01       Impact factor: 5.695

2.  The role of gene and cell therapy in the era of health care reform.

Authors:  Walter H Ettinger; Terence R Flotte
Journal:  Hum Gene Ther       Date:  2011-10-24       Impact factor: 5.695

3.  It's time to end RAC review of gene therapy protocols.

Authors:  Gerard J McGarrity
Journal:  Mol Ther       Date:  2012-06       Impact factor: 11.454

4.  Developing a balanced business model for gene therapy.

Authors:  Alex Philippidis
Journal:  Hum Gene Ther       Date:  2011-05-17       Impact factor: 5.695
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.